About Andrew Altschuler
Andrew Altschuler is co-founder, chairman, president and chief executive officer of GOA Therapeutics. The West Palm Beach company develops drug candidates for alcohol intoxication and poisoning. Its candidate GOA26 is moving toward an IND filing and clinical studies.
Altschuler is a serial entrepreneur with over 30 years of business experience. He led GOA from concept to an emerging biopharmaceutical company. He assembled a team of scientists, physicians and drug-development executives. He directs corporate strategy, financing, business development and capital-markets activities.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Andrew Altschuler in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Altschuler works with at each company, as listed on that company's latest Form D.
